Acquisitions and Joint Venture - Narrative (Details) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 17, 2021	Mar. 31, 2022	Jan. 31, 2023	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2020	Feb. 01, 2021	Jan. 19, 2021
Business Acquisition [Line Items]
Useful life				16 years
Goodwill				$ 3,609,700,000	$ 2,574,000,000
Proceeds from sale of interest in a subsidiary		$ 52,100,000		$ 52,100,000	$ 0	$ 0
Payments to form joint venture		10,000,000
Equity method investments		90,000,000
Equity method investment realized gain		56,900,000
Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System
Business Acquisition [Line Items]
Goodwill							$ 0
Essilor International SAS
Business Acquisition [Line Items]
Payments to form joint venture		$ 10,000,000
SightGlass Vision, Inc.
Business Acquisition [Line Items]
Equity method investment, ownership percentage		50.00%
Customer relationships
Business Acquisition [Line Items]
Useful life				19 years
Trademarks
Business Acquisition [Line Items]
Useful life				15 years
Line of Credit | Term Loan Facility 2021
Business Acquisition [Line Items]
Proceeds from line of credit	$ 1,500,000,000
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event
Business Acquisition [Line Items]
Purchase price to acquire business			$ 875,000,000
Payments to acquire business			675,000,000
Payables incurred in acquisition			200,000,000
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables First Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			50,000,000
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Second Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			50,000,000
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Third Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			50,000,000
Cook Medicals Reproductive Health Business | Forecast | Subsequent Event | Payables Fourth Installment
Business Acquisition [Line Items]
Payables incurred in acquisition			$ 50,000,000
Generate Life Sciences
Business Acquisition [Line Items]
Payments to acquire business	$ 1,663,000,000
Ownership percentage	100.00%
Measurement period adjustment to goodwill				$ 115,300,000
Actual revenue generated				249,500,000
Actual net income generated				$ 27,800,000
Goodwill	$ 1,177,300,000
Generate Life Sciences | Customer relationships
Business Acquisition [Line Items]
Useful life				20 years
Generate Life Sciences | Trademarks
Business Acquisition [Line Items]
Useful life				15 years
Generate Life Sciences | Line of Credit | Term Loan Facility 2021
Business Acquisition [Line Items]
Proceeds from line of credit	$ 1,500,000,000
Privately-Held Medical Device Company, Spectacle Lenses, Portion Attributable To Former Equity Interest Owners
Business Acquisition [Line Items]
Undiscounted range of the contingent consideration, minimum								$ 0
Undiscounted range of the contingent consideration, maximum								$ 139,100,000
Payment to settle former equity interest owners		$ 42,900,000
Equity investment gain realized before acquisition of remaining equity interest				$ 12,200,000
Contingent consideration				$ 31,800,000